Skip to main content
JHS Svendgaard Laboratories Ltd. logo

JHS Svendgaard Laboratories Ltd. — Investor Relations & Filings

Ticker · JHS ISIN · INE544H01014 LEI · 335800NYNAOOMRTTWW75 BSE.NS Manufacturing
Open in API
Filings indexed 678 across all filing types
Latest filing 2023-01-19 Regulatory Filings
Country IN India
Listing BSE.NS JHS

About JHS Svendgaard Laboratories Ltd.

https://www.svendgaard.com/

JHS Svendgaard Laboratories Ltd. is a specialized manufacturer of oral care products, operating primarily through contract manufacturing and private labeling arrangements. The company provides end-to-end solutions for oral hygiene, including the production of toothbrushes, toothpastes, mouthwashes, and specialized dental care items. It maintains large-scale manufacturing facilities equipped to handle high-volume production for global and domestic FMCG brands. In addition to its business-to-business operations, the company manages its own consumer brand, Aquawhite, which focuses on innovative oral care solutions for various age groups, including a significant range of licensed character-based products for children. The organization emphasizes quality control and technical expertise in oral health product development, catering to diverse market segments through a robust supply chain and distribution network.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming no requests for dematerialization or rematerialization of securities for the quarter ending December 31, 2022. It is addressed to stock exchanges and signed by the company secretary and the registrar & transfer agent. The document is short (2775 characters) and serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. Therefore, it fits the category of a Regulatory Filing (RNS), which includes officer certifications and compliance confirmations under SEBI regulations.
2023-01-19 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges regarding the closure of the trading window for insiders ahead of the announcement of quarterly financial results. It references the upcoming financial results for the quarter ended December 31, 2022, but does not contain any financial data or results itself. The document is short (1556 characters) and serves as an announcement related to compliance and insider trading restrictions rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and procedural announcements.
2022-12-30 English
Scheme of Arrangement
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding a Composite Scheme of Arrangement involving demerger and amalgamation of companies. It references a Company Petition heard by the National Company Law Tribunal (NCLT) and includes details about the hearing dates, tribunal orders, and procedural steps such as notices to authorities and publication in newspapers. The content focuses on legal and procedural updates related to the scheme approval process rather than financial results, management changes, or shareholder voting outcomes. It is not a full financial report, earnings release, or management discussion. The document is a regulatory announcement about the status and next steps of a corporate restructuring scheme, including tribunal orders and procedural compliance. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-12-21 English
Related Party Transaction
Regulatory Filings Classification · 95% confidence The document is a disclosure of Related Party Transactions for the half-year ended September 30, 2022, submitted to stock exchanges as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It contains detailed tabular data on transactions between the company and related parties, including remuneration, loans, advances, and other transactions. The document is not a full financial report but a regulatory disclosure specific to related party transactions. It is not an announcement of a report but the actual disclosure itself. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-11-25 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 100% confidence The document is a transcript of a conference call held on November 15, 2022, discussing the financial results for the quarter and half year ended September 30, 2022. It includes detailed management commentary on financial performance, business developments, product segments, and Q&A with investors. The presence of a full transcript of the earnings call with management and investor questions clearly identifies this as a Call Transcript (CT). The document length (15,000 characters) and content confirm it is not a brief announcement or summary but a full transcript. Therefore, the appropriate classification is Call Transcript (CT).
2022-11-21 English
NCLT/ Court Convened Meeting
Regulatory Filings
2022-11-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.